World Rank
#233,922
Biopharmadive.com
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Visits & Engagement
On PC & mobile, in the last 6 months
Engagements
March, 2025
| Overall Visits | 237.61K |
| Time On Site | 00:01:20 |
| Pages per Visit | 1.55 |
| Bounce Rate | 57.5% |
Traffic Sources
On PC, in the last 3 months. Click on the column for drilldown
Geography
On PC, in the last month
Traffic by countries
| United States | |
| Korea, Republic of | |
| India | |
| United Kingdom | |
| Canada |
Review
By popularity Biopharmadive.com ranked 233 922th in the World, 84 489th place in United States, 63th place in category "Health / Biotechnology and Pharmaceuticals"
Has weak positive dynamics in attracting traffic. In the period from september'24 to march'25 the attendance of this site increased from 267 476 to 292 990 (+9.10%).
For March '2025 there were 237 606 visits. The average visitor per session views 1.55 page(s) and spends 1 minute(s) 20 second(s) on the site. At the same time the bounce rate is 57.50%.
The most popular site uses in United States, attracting from this country 59.07% of overall traffic.
Structure of traffic sources: the highest traffic "Search" (48.04%), the second most important "Direct" (43.47%), followed by "Referrals" (6.08%), then "Social" (1.89%), then "Display Ads" (0.37%) and in the last place "Mail" with a share 0.12%.
Referrals
6.08%
Top Referring Sites:
| Domain | share/change |
|---|---|
|
|
13.97%
|
|
|
11.94%
|
|
|
8.30%
|
|
|
7.69%
-79.71%
|
|
|
7.69%
|
Top Destination Sites:
| Domain | share/change |
|---|---|
|
|
37.23%
41.65%
|
|
|
15.38%
|
|
|
13.07%
|
|
|
7.90%
-10.17%
|
|
|
4.46%
|
Search
48.04%
Organic Keywords:
| Keyword | share/change |
|---|---|
| biopharma dive |
9.93%
712.74%
|
| stemcentrx |
1.87%
|
| zolgensma |
1.11%
|
| dupixent |
1.08%
|
| abbvie stemcentrx |
1.05%
|
Paid Keywords:
No Data Available
Social Networks
1.89%